AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
Healthcare
ProAssurance (PRA) Soars 12.6%: What's Next?
July 31, 2024 05:00 PM AEST| By Team Kalkine MediaProAssurance (PRA) shares surged 12.6% in the last trading session, ending at $13.16. This increase was supported by significant trading volume, surpassing the usual activity. In contrast, the stock had previously declined by 4.2% over the past month...
Teva Pharmaceutical Industries (NYSE:TEVA) Q2 2024 Earnings Overview
July 31, 2024 05:00 PM AEST| By Team Kalkine MediaThe Motley Fool Stock Advisor analyst team has recently highlighted their top 10 stock selections, notably excluding Teva Pharmaceutical Industries,(NYSE:TEVA),.The chosen stocks are anticipated to yield significant returns in the future.,Reflecting...
Procter & Gamble falls short of sales estimates: Is it still a strong long-term investment?
July 31, 2024 12:54 AM AEST| By InvezzProcter & Gamble Co (NYSE: PG), the household staple known for its broad range of consumer goods, reported weaker-than-expected sales for the fourth quarter on Tuesday. Despite this, experts suggest the stock remains a strong long-term inve...
SCOR Q2 Loss Amid Rising Revenues; L&H CEO to Depart
July 30, 2024 10:10 PM AEST| By Team Kalkine MediaHeadlines:,SCOR Reports Q2 Loss Amid Mixed Revenue Growth,P&C Insurance Revenue Sees Notable Increase; L&H Revenue Marginally Declines,L&H CEO Frieder Knupling Steps Down; Thierry Leger Assumes Role,SCOR SE (OTC:SZCRF), a leading French reinsurance p...
Calquence-Venetoclax Combo Shows Promise; Impact on Healthcare Stocks
July 29, 2024 10:19 PM AEST| By Team Kalkine MediaHeadlines:,Amplify Trial Results Show Significant Improvement with Calquence Combination,Trend Favoring Calquence in Overall Survival Observed, Awaiting Further Data,Chronic Lymphocytic Leukemia Cases Expected to Rise Globally,AstraZeneca(NASDAQ:AZN)...
GSK’s Arexvy RSV Vaccine Gains CHMP Approval for Ages 50-59
July 29, 2024 10:14 PM AEST| By Team Kalkine MediaHeadlines:,GSK’s Arexvy RSV Vaccine Receives Positive CHMP Opinion for Adults Aged 50-59 at Higher Risk,Expansion of Arexvy Approval Could Include Adults Aged 50-59 by September 2024,GSK’s RSV Vaccine Trials Progress in Multiple Regions, Including th...
Merck's Q2 2024 Earnings Preview: Key Trends and Future Prospects
July 29, 2024 09:57 PM AEST| By Team Kalkine MediaHeadlines:,Q2 2024 Revenue and Earnings Expectations,Stock Performance and Market Trends Analysis,Valuation Insights and Future Outlook,Merck (NYSE:MRK) is scheduled to unveil its Q2 2024 financial results on Tuesday, July 30. Anticipations are set f...
Pfizer's Q2 2024 Outlook: Revenue Projections and Market Performance
July 29, 2024 09:52 PM AEST| By Team Kalkine MediaHeadlines:,Pfizer's Q2 Report and Revenue Expectations,Historical Stock Performance and Market Trends,Valuation Insights and Future Predictions,Pfizer (NYSE:PFE) is set to disclose its Q2 2024 financial results on Tuesday, July 30. Analysts anticipat...
How to capitalize on the weight loss revolution with Tema Obesity & Cardiometabolic ETF (HRTS)
July 28, 2024 12:23 AM AEST| By InvezzThe weight loss revolution sparked by Novo Nordisk last year is attracting many investors towards the high risk biotech sector. An ETF like HRTS gives a lower risk exposure to the sector.
Bausch Health Addresses Bankruptcy Speculation, Affirms No Plans for Filing
July 26, 2024 03:27 AM AEST| By Team Kalkine MediaHeadlines:,Bausch Health responds to bankruptcy,rumors,, clarifying that it is not contemplating bankruptcy.,The company emphasizes its commitment to,maintaining,financial stability and addressing market concerns.,Bausch Health aims to reassure stake...
HCA Healthcare Stock Soars as Company Exceeds Expectations and Upgrades Revenue Forecast
July 24, 2024 05:00 PM AEST| By Team Kalkine MediaSummary:,- HCA Healthcare's stock increased by over 5% on Tuesday.,- The company's performance exceeded expectations.,- HCA Healthcare raised its full-year forecast.,- Net income rose to $1.46 billion, with earnings per share reaching $5.53.,- Sales...
Novo Nordisk’s Wegovy approved by MHRA in the UK for cardiovascular prevention
July 24, 2024 03:26 AM AEST| By InvezzThe UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved Novo Nordisk’s weight loss drug, Wegovy, for the prevention of serious cardiovascular events in overweight and obese adults. This landmark decision mar...
Novartis (SWX: NOVN) Reports Robust Q2 Growth, Raises FY 2024 Guidance
July 19, 2024 04:07 PM AEST| By Team Kalkine MediaNovartis (SWX: NOVN) has delivered strong financial results in the second quarter of 2024, leading to a raised full-year bottom-line guidance. The company achieved notable increases in net sales and core operating income, highlighting the success of...
GE HealthCare (Nasdaq: GEHC) Expands AI Capabilities with Intelligent Ultrasound Acquisition
July 18, 2024 06:47 PM AEST| By Team Kalkine MediaGE Healthcare (Nasdaq: GEHC) has announced a strategic acquisition aimed at bolstering its capabilities in clinical artificial intelligence (AI) software. The agreement involves acquiring Intelligent Ultrasound Group PLC’s (Intelligent Ultrasound) AI...
UnitedHealth Group (NYSE: UNH) Reports Strong Second Quarter 2024 Results Amid Growth and Challenges
July 17, 2024 03:05 PM AEST| By Team Kalkine MediaUnitedHealth Group (,NYSE: UNH,) has announced its second quarter 2024 financial results, demonstrating robust performance driven by significant growth across its Optum and UnitedHealthcare segments. The company reported revenues totalling $98.9 bill...
UnitedHealth Q2 profit beats expectations amid recovery from tech unit hack
July 16, 2024 11:12 PM AEST| By InvezzUnitedHealth Group (NYSE: UNH) announced a stronger-than-anticipated second-quarter profit on Tuesday, driven by robust performance in its healthcare services division. The company also revised its cost estimates related to a cybersecurity breach at...
Mainz Biomed N.V. (NASDAQ: MYNZ), Pursues Breakthrough Device Designation for Next-Generation Colorectal Cancer Test
July 09, 2024 07:01 PM AEST| By Team Kalkine MediaMainz Biomed N.V. (,NASDAQ: MYNZ,), a frontrunner in molecular genetics diagnostics with a focus on early cancer detection, has reached a pivotal milestone by submitting an application to the U.S. Food and Drug Administration (FDA) for Breakthrough D...
Grifols Founding Family and Brookfield team up for potential €5.5B takeover bid
July 08, 2024 10:20 PM AEST| By InvezzThe Grifols founding family and Canadian alternative asset manager Brookfield have joined forces to launch a potential takeover bid for Spanish pharmaceutical company Grifols. T he move, if successful, would result in Grifols being delisted from the...
Mediwound stock soars 60% on takeover interest
July 06, 2024 12:27 AM AEST| By InvezzMediwound Ltd (NASDAQ: MDWD) rallied a whopping 60% on Friday following a report that Solventum Corp (NYSE: SOLV) is interested in buying the biopharmaceutical firm. Solventum has reportedly valued the Israel based company at $34 per share. Med...
Novo Nordisk reprimanded by UK for failing to disclose £7.9 M in payments
July 05, 2024 11:38 PM AEST| By InvezzIn an industry where transparency is paramount, Novo Nordisk, the Danish pharmaceutical giant known for its diabetes drug Ozempic and weight-loss treatment Wegovy, has found itself in hot water. The company has been publicly reprimanded by the Associ...
